Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Angiodynamics Inc (NQ: ANGO )

18.20 USD -0.28 (-1.52%)
Official Closing Price Updated: 4:03 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Angiodynamics Inc

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
AngioDynamics Reports Fiscal 2018 Fourth Quarter and Full-Year Financial Results
AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, oncology and surgery, today announced... 
From Business Wire News Releases
AngioDynamics to Report Fiscal 2018 Fourth Quarter and Full-Year Financial Results on July 11, 2018
AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, surgery and oncology, today announced that it... 
From Business Wire News Releases
Research Report Identifies AngioDynamics, Kaiser Aluminum, Mammoth Energy Services, Meridian Bioscience, Merrimack Pharmaceuticals, and Energizer with Renewed Outlook — Fundamental Analysis, Calculati
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of AngioDynamics, Inc.... 
From GlobeNewswire News Releases
AngioDynamics to Present at Two Investor Conferences in May
AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, surgery and oncology, today announced that it... 
From Business Wire News Releases
Blog Exposure - Waters Corp. to Significantly Expand its Precision Chemistry Facility in Massachusetts
From ACCESSWIRE
Recent Analysis Shows Multi-Color, Madrigal Pharmaceuticals, SPX, AngioDynamics, Atara Biotherapeutics, and Quanex Building Products Market Influences — Renewed Outlook, Key Drivers of Growth
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Multi-Color Corporation... 
From GlobeNewswire News Releases
AngioDynamics Reports Fiscal 2018 Third Quarter Financial Results
AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, surgery and oncology, today announced... 
From Business Wire News Releases
AngioDynamics to Present at the Needham 17th Annual Healthcare Conference
AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, surgery and oncology, today announced that... 
From Business Wire News Releases
AngioDynamics to Report Fiscal 2018 Third Quarter Financial Results on March 29, 2018
AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, surgery and oncology, today announced that it... 
From Business Wire News Releases
AngioDynamics to Present at the Barclays Global Healthcare Conference
AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, surgery and oncology, today announced that Jim... 
From Business Wire News Releases
Investor Expectations to Drive Momentum within Regal Beloit, Kaiser Aluminum, AngioDynamics, Mulesoft, Assembly Biosciences, and Woodward — Discovering Underlying Factors of Influence
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Regal Beloit Corporation... 
From GlobeNewswire News Releases
AngioDynamics Receives FDA Expedited Access Pathway Designation for the NanoKnife® System for the Treatment of Stage III Pancreatic Cancer
AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, surgery and oncology, today announced that the... 
From Business Wire News Releases
AngioDynamics Reports Fiscal 2018 Second Quarter Financial Results
AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, surgery and oncology, today announced financial... 
From Business Wire News Releases
AngioDynamics to Present at the J.P. Morgan Healthcare Conference
AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that Jim... 
From Business Wire News Releases
AngioDynamics to Report Fiscal 2018 Second Quarter Financial Results on January 4, 2018
AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that it... 
From Business Wire News Releases
AngioDynamics Reports Fiscal 2018 First Quarter Results
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today reported first quarter... 
From GlobeNewswire News Releases
Outcomes in a Nurse-Led Peripherally Inserted Central Catheter Program: A Retrospective Cohort Study Published in CMAJ Open
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today the publication... 
From GlobeNewswire News Releases
AngioDynamics to Report Fiscal 2018 First Quarter Financial Results
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report... 
From GlobeNewswire News Releases
AngioDynamics to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Michael C.... 
From GlobeNewswire News Releases
AngioDynamics to Present at the 2017 Morgan Stanley Global Healthcare Conference
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Jim... 
From GlobeNewswire News Releases
AngioDynamics to Present at the 2017 Canaccord Genuity Growth Conference
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Michael... 
From GlobeNewswire News Releases
IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of AngioDynamics, Inc.
Lundin Law PC, a shareholder rights firm, announces that it is investigating claims against AngioDynamics, Inc. (“AngioDynamics” or the “Company”) (Nasdaq: ANGO) concerning possible violations of... 
From Business Wire News Releases
INVESTOR ALERT: Monteverde & Associates PC Announces an Investigation of AngioDynamics, Inc. - ANGO
Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a boutique securities firm headquartered at the Empire State Building in New York City announces it is investigating... 
From PR Newswire
INVESTOR ALERT: Goldberg Law PC Announces an Investigation of AngioDynamics, Inc.
Goldberg Law PC, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of AngioDynamics, Inc. (“AngioDynamics” or the “Company”) (Nasdaq:... 
From Business Wire News Releases
Lifshitz & Miller LLP Announces Investigation of Acacia Communications, Inc., AngioDynamics, Inc., ClubCorp Holdings, Inc., HD Supply Holdings, Inc., Ocular Therapeutix, Inc., Repros Therapeutics Inc
From PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AngioDynamics, Inc. - ANGO
From ACCESSWIRE
IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of AngioDynamics, Inc. and Encourages Investors with Losses to Contact the Firm
Khang & Khang LLP (the “Firm”) announces that it is investigating claims against AngioDynamics, Inc. (“AngioDynamics” or the “Company”) (Nasdaq: ANGO) concerning possible violations of federal... 
From Business Wire News Releases
ANGIODYNAMICS (ANGO) INVESTOR ALERT: Legal Investigation for Potential Securities Law Violations
Girard Gibbs investigates legal claims on behalf of investors of AngioDynamics, Inc. (NASDAQ:ANGO). 
From Business Wire News Releases
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of AngioDynamics, Inc.
Levi & Korsinsky announces it has commenced an investigation of AngioDynamics, Inc. concerning possible violations of federal securities laws. 
From Business Wire News Releases
IMPORTANT INVESTOR ALERT: Lundin Law PC Announces an Investigation of AngioDynamics, Inc.
Lundin Law PC, a shareholder rights firm, announces that it is investigating claims against AngioDynamics, Inc. (“AngioDynamics” or the “Company”) (Nasdaq: ANGO) concerning possible violations of... 
From Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.